In an exchange filing, Honasa said that Yatish has been appointed today as CBO and has also been designated a senior ...

This development marks a strategic expansion into a new product category and industry vertical for the company.

The audit, which covered multiple active pharmaceutical ingredients (APIs), was conducted from 14 April to 18 April 2025.